GSK, Novartis concede more ground in ACCC’s Voltaren case
Competition & Consumer Protection March 6, 2018 8:07 pm By Cat Fredenburgh | Melbourne

GlaxoSmithKline and Novartis have made another admission in a case brought by the ACCC alleging the drug giants made misleading claims in marketing their Voltaren Osteo […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.